Strategic Diagnostics Inc. and Broin and Associates, Inc. Announce Development Contract for Application of SDI Bacteriophage Technology in Ethanol Production.

NEWARK, Del. -- Strategic Diagnostics Inc. (Nasdaq:SDIX) and Broin and Associates, Inc., a division of the Broin Companies, today announced the signing of a contract to develop application(s) based on SDI's patent-pending technology utilizing bacteriophage as selective agents. The application(s) will directly support Broin and Associates proprietary BPX technologies for ethanol production. Terms of the agreement were not disclosed.

Earlier this year, SDI announced the publication of its patent application, including claims addressing problems in bio-fermentation that pertain to the microbiological contamination of the process.

Rob Broin, Chief Technology Officer at Broin and Associates, commented, "Broin Companies have aggressively invested in the development of technologies that are demonstrating industry-leading performance in the production of ethanol. The Broin BPX technology consistently delivers industry leading yields and plant efficiencies while producing the highest quality co-products. We believe that SDI's technology and expertise can meaningfully contribute to Broin process technologies."

"We are delighted to be working with Broin Companies," commented Matt Knight, President and CEO of SDI. "In addition to their industry-leading position as a builder and operator of ethanol facilities, they are great innovators with a tremendous track record for developing breakthrough technologies. We look forward to working with Broin Companies to further their historic leadership position in raw starch production of ethanol, and are excited to play a key scientific role in the ongoing development and accelerating evolution of ethanol production."

Process contamination is a challenge in all industrial fermentation systems that start with a raw or non-sterile feedstock, such as corn, or operate in a non-sterile environment. In such applications, the fermentation process may be operated in ways that compromise the efficiency and yield of their fermentation processes in order to prevent contamination from overwhelming the production organism. SDI's technology controls contaminating bacteria in industrial fermentations while optimizing the process to produce a preferential environment for the production organism. It allows the customer to reduce the number of failed batches, increase the yield per batch, eliminate the use of undesirable chemicals in their media and formulations, and better optimize the overall system chemistry for optimum production.

About Broin Companies

The Broin Companies are a highly specialized and integrated technology development, production management and marketing company in the ethanol industry. As the second largest producer in the industry, the Broin companies have designed and constructed 23 operating ethanol plants and currently have nine projects under construction or development.

About Strategic Diagnostics Inc.

Strategic Diagnostics Inc. develops, manufactures and markets biotechnology-based detection solutions to a diverse customer base, across multiple industrial and human health markets. Through the application of its core competencies of creating custom antibodies, bio-reagents, and assay development, the Company produces unique, sophisticated diagnostic testing and reagent systems that are responsive to customer needs for improved production efficiencies, while proactively diagnosing and preventing problems in key work processes. Customers benefit with quantifiable "return on investment" by reducing time, labor, and/or material costs. The Company is focused on sustaining this competitive advantage by leveraging its expertise in immunology, proteomics, bio-luminescence and other bio-reactive technologies and continuing its successful customer-focused research and development efforts.

This news release contains forward-looking statements reflecting SDI's current expectations. When used in this press release, the words "anticipate", "could", "enable", "estimate", "intend", "expect", "believe", "potential", "will", "should", "project", "plan" and similar expressions as they relate to SDI are intended to identify said forward-looking statements. Investors are cautioned that all forward-looking statements involve risks and uncertainties, which may cause actual results to differ from those anticipated by SDI at this time. Such risks and uncertainties include, without limitation, changes in demand for products, delays in product development, delays in market acceptance of new products, retention of customers and employees, adequate supply of raw materials, the successful integration and consolidation of the Maine production facilities, inability to obtain or delays in obtaining fourth party, including AOAC, or required government approvals, the ability to meet increased market demand, competition, protection of intellectual property, non-infringement of intellectual property, seasonality, and other factors more fully described in SDI's public filings with the U.S. Securities and Exchange Commission.